NPI | Name | Type | Address |
---|---|---|---|
PHARMD William Anderson |
Individual |
1675 18th Ave Suite3 Greeley, CO |
|
DR. PHARMD Shawn-patrick Hegner |
Individual |
2121 E Harmony Rd Suite 170 Fort Collins, CO |
|
PHARMD Amanda Michelle Christman |
Individual |
2121 E Harmony Rd Ste 170 Fort Collins, CO |
|
MRS. PHARM D. Cheryl Kay Nacos |
Individual |
1024 S Lemay Ave Fort Collins, CO |
|
Cara Harshberger |
Individual |
2121 E Harmony Rd Unit 170 Fort Collins, CO |
|
Vincent Andrew Vidaurri |
Individual |
2121 E Harmony Rd Unit 170 Fort Collins, CO |
|
PHARM.D. Allison Machan Faltermier |
Individual |
2121 E Harmony Rd Unit 170 Fort Collins, CO |
|
DR. PHARM.D. Joseph Anthony Kaiser |
Individual |
750 Wellington Ave Grand Junction, CO |
|
RPH Stacy Spenard |
Individual |
2000 Boise Ave Loveland, CO |
|
MRS. PHARMD Lindsay Sinclair |
Individual |
2121 E Harmony Rd Suite 170 (pharmacy) Fort Collins, CO |
|
PHARM.D. Tomi Folkestad |
Individual |
2121 E Harmony Rd Suite 170 Fort Collins, CO |
|
PHARMD Carrie Allen |
Individual |
2121 E Harmony Rd Suite 170 Fort Collins, CO |
|
PHARMD Evan John Slater |
Individual |
4700 Hale Pkwy Ste 400 Denver, CO |
|
PHARMD, MS Ekim Ekinci |
Individual |
10240 Park Meadows Dr Lone Tree, CO |
|
PHARMD Whitney Work |
Individual |
750 Wellington Ave Grand Junction, CO |
|
PHARMD Kate Deen Taucher |
Individual |
525 N Foote Ave Suite 202 Colorado Springs, CO |
|
DR. PHARMD, BCOP Lida Bighash |
Individual |
660 Bannock St Denver, CO |
|
PHARMD Laura Pultorak |
Individual |
1311 N Mildred Rd Cortez, CO |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |